India Cancer Immunotherapy Market Analysis

India Cancer Immunotherapy Market Analysis


$ 3999

India's cancer immunotherapy market is expected to witness growth from $2.04 Bn in 2022 to $4.41 Bn in 2030 with a CAGR of 10.1% for the forecasted year 2022-2030. Supportive government policies for promoting cancer care and the growing acceptance of cancer immunotherapy in India are responsible for the growth of the market. The Indian cancer immunotherapy market is segmented by type, application, and end user. Swisschem Healthcare, Epigeneres Biotech, and Bayer are the major players in the Indian cancer immunotherapy market.

ID: IN10INPH032 CATEGORY: Pharmaceuticals GEOGRAPHY: India AUTHOR: Dr. Parul Choudhary

Buy Now

India Cancer Immunotherapy Market Executive Analysis

India's cancer immunotherapy market is expected to witness growth from $2.04 Bn in 2022 to $4.41 Bn in 2030 with a CAGR of 10.1% for the forecasted year 2022-30. In the Union budget for 2023–24, the Ministry of Health and Family Welfare was given an allocation of $1.08 Bn, an increase of 12.6% from the revised Budget estimates for 2022–23. The Central and State Governments budgeted spending on the health sector at 2.1% of GDP in Financial Year (FY) 23 and 2.2% in FY22, up from 1.6% in FY21, according to the Economic Survey 2022–23. However, the budgeted expenditure for the health sector in the current budget, which is the final full budget of the Modi 2.0 government, was almost 1.98 % of the GDP. This is when the National Health Policy, 2017 calls for a time-bound increase in public health spending to 2.5% of GDP by 2025. India's healthcare expenditure as a %age of GDP is much below the global average and that of other emerging and developed countries due to continued minimal allocation to the healthcare sector.

Around 2.7 Mn cancer patients are anticipated in India by 2020. 13.9 lakh new cancer patients are registered each year. About 8.5 lakh people die in India each year from cancer. Recent decades have seen tremendous growth in scientific developments for the treatment of cancer. Cancer research is one area of medicine that has benefitted from this enormous advancement. In addition to a greater understanding of the condition, there are many cutting-edge cancer therapies available today. Immunotherapy for cancer is one of these ground-breaking therapies. Cancer immunotherapy is a form of biological or targeted therapy that use the body's own immune system to eradicate cancer cells. Other names for immunotherapy for cancer include immuno-oncology.

The cancer patient's immune system is assisted by immunotherapy in the battle against cancerous cells. Immunotherapy, which was introduced in India a few years ago, is improving every day. The best hospitals in the nation's healthcare system offer immunotherapy to their patients. Compared to a few decades ago, patients today have better access to the type of cancer treatment that their clinical needs require. Synthetic antibodies created in a lab are known as monoclonal antibodies. The immune system often makes antibodies in reaction to a threat, and these antibodies locate and target the threat to remove it from the body. The way that monoclonal antibodies function is similar. By interfering with cancer cells' proteins and making them visible to immune cells, monoclonal antibodies can aid the immune system in locating cancer cells. Additionally, it can aid in weakening cancer cells so that the immune system can eliminate them. Proteins called cytokines to aid in the body's destruction of aberrant or harmful cells. Proteins like interleukin and interferon are examples of cytokines. These proteins make cancer cells more apparent to the immune system and disrupt the processes through which cancer cells divide and proliferate. They also enhance the functionality and expansion of killer T-cells.

India Cancer Immunotherapy Market Analysis

Market Dynamics

Market Growth Drivers

The National Cancer Grid and the Ayushman Bharat scheme, which gives Mns of people access to healthcare, are just two of the initiatives the Indian government has launched to improve cancer care in the nation. In India, there is a growing tendency toward the acceptance of cancer immunotherapy treatments as awareness of these therapies rises. India has a rising cancer prevalence, which presents a substantial market opportunity for cancer immunotherapy treatments. These factors contribute significantly to the growth of the Indian cancer immunotherapy market.

Market Restraints

The high cost of these treatments is one of the key factors limiting the growth of the Indian cancer immunotherapy market. Not many patients can afford immunotherapies because they are frequently pricey. Fewer patients can receive these medicines as a result of the market's size being constrained. In India, immunotherapy therapies are not widely accessible, and not all patients can receive them. This is due to the fact that some of these therapies demand sophisticated infrastructure, such as specialized medical facilities, skilled employees, and cutting-edge machinery. Finally, immunotherapy may have serious adverse effects, which may restrict its application in some individuals. Patients may develop immune-related side effects, which can occasionally be quite serious and include organ or tissue inflammation. Because of this, the use of immunotherapy may be restricted in patients who are not suitable for it.

Competitive Landscape

Key Players

  • Pharmacyclics (IND)
  • Healthkind Labs (IND)
  • Arlak Biotech (IND)
  • Swisschem Healthcare (IND)
  • Epigeneres Biotech (IND)
  • Bayer
  • Bristol-Myers Squibb
  • Eli Lily
  • F. Hoffmann-La Roche
  • Pfizer
  • Johnson & Johnson
  • Merck

Recent Deals

January 2023- The Drugs Controller General of India (DCGI) has authorized MSD's anti-PD-1 medication Keytruda (pembrolizumab) for the treatment of persistent, recurring, or metastatic cervical cancer in adults whose tumours express PD-L1 with a CPS 1. MSD is a trademark of Merck & Co. In addition, Keytruda has been approved for the first-line therapy of adults with HER-2 negative gastroesophageal junction adenocarcinoma or locally advanced unresectable or metastatic oesophagal cancer that expresses PD-L1 with a CPS 10. The Phase 3 Keynote 590 and 826 investigations for oesophagal and cervical cancer, respectively, served as the foundation for the approval.

Healthcare Policies and Regulatory Landscape

The Indian government introduced Ayushman Bharat, a national health insurance program, in 2018. It offers economically disadvantaged groups in a society free health coverage worth up to INR 5 lakhs per household per year. Immunotherapy is one of the cancer treatments covered by the program. Government employees, retirees, and their families are all given access to healthcare through the Central Government Health Scheme (CGHS) program. Up to a specific amount, it pays for the cost of cancer treatments, including immunotherapy. There are health insurance programs in several Indian states that cover cancer treatments, including immunotherapy. For instance, Telangana's Arogyasri Health Insurance Scheme covers cancer treatments, including immunotherapy. The Indian government has also established several cancer treatment centres that provide patients with free cancer therapy. For instance, the Tata Memorial Hospital in Mumbai provides patients who cannot afford it with free cancer care, including immunotherapy.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Cancer Immunotherapy Segmentation

By Type (Revenue, USD Billion):

  • Monoclonal Antibodies
  • Cancer Vaccines
  • Checkpoint Inhibitors
  • Immunomodulators
  • PD-1/PD-L1
  • CTLA-4

By Application (Revenue, USD Billion):

  • Lung Cancer
  • Breast Cancer
  • Head and Neck Cancer
  • Prostate Cancer
  • Colorectal Cancer
  • Melanoma
  • Others

By End User (Revenue, USD Billion):

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers (ASCs)
  • Cancer Research Centers

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

 

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

 

 

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.

 

 

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.

Swisschem Healthcare, Epigeneres Biotech, and Bayer are the major players in the India cancer immunotherapy market.

The India cancer immunotherapy market is expected to grow from $2.04 Bn in 2022 to $4.41 Bn in 2030 with a CAGR of 10.1% for the forecasted year 2022-2030.

The India cancer immunotherapy market is segmented by type, application, and end user.


This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 05 July 2023
Updated by: Riya Doshi

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up